螺[色满-2,1'-环己烷]-4-酮, 98%

3,4-dihydrospiro[1-benzopyran-2,1'-cyclohexane]-4-one

MG-277, ≥99%

MG-277

Thalidomide-NH-C6-NH2 hydrochloride, ≥98%

Thalidomide-NH-C6-NH2 hydrochloride

（反式-2-（3-（三氟甲氧基）苯基）环丙基）甲醇, 98%

(trans-2-(3-(trifluoromethoxy)phenyl)cyclopropyl)methanol

脱氧土大黄苷, 99%

Desoxyrhaponticin

3-硝基苯叉基乙酰乙酸乙酯, 98%

Methyl 3-nitrobenzylideneacetoacetate

2-Bromo-4-(iso-propyl)pyrimidine-5-boronic acid, 98%

2-Bromo-4-(iso-propyl)pyrimidine-5-boronic acid

螺[色满-2,4'-哌啶]盐酸盐, 98%

3,4-dihydrospiro[chromene-2,4'-piperidine] hydrochloride

MRTX849 acid, ≥99%

MRTX849 acid

Thalidomide-NH-C6-NH2 TFA, 98%

Thalidomide-NH-C6-NH2 TFA

（反式-2-（4-氯-2-氟苯基）环丙基）氨基甲酸叔丁酯, 99.9%

tert-butyl (trans-2-(4-chloro-2-fluorophenyl)cyclopropyl)carbamate

3-羟基-4-甲基-2(3H)-噻唑酮, 99%

3-hydroxy-4-methylthiazole-2(3H)-thione

Verubecestat (MK-8931), 99.9%

Verubecestat (MK-8931)

2-Bromo-4-(morpholino)phenylboronic acid, 98%

2-Bromo-4-(morpholino)phenylboronic acid

（±）顺-2,5-双（3,4,5-三甲氧基苯基）-1,3-二氧戊环

(±) cis-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane

99%

氟奋乃静庚酸酯

European Pharmacopoeia (EP) Reference Standard

3-(5-甲基-3-异噁唑基)-6-[(1-甲基-1H-1,2,3-三氮唑-4-基)甲氧基][1,2,4]三氮唑并[3,4-a]酞嗪, ≥98%

3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine

螺[芴-9,7'-二苯并吖啶], 98%

Spiro[fluorene-9,7'-dibenzo[c,h]acridine]

MRTX849 ethoxypropanoic acid, ≥99%

MRTX849 ethoxypropanoic acid

Thalidomide-NH-CBP/p300 ligand 2, ≥99%

Thalidomide-NH-CBP/p300 ligand 2